deoxypyridinoline has been researched along with norethindrone acetate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, LH; Jorgensen, LN; Loh, FH; Yu, SL | 1 |
| Altavilla, D; Cincotta, M; Corrado, F; Crisafulli, A; D'Anna, R; Frisina, N; Gaudio, A; Ientile, R; Lasco, A; Morabito, N; Pizzoleo, MA; Squadrito, F; Vergara, C | 1 |
| Adamo, EB; Altavilla, D; Bartolone, S; Bitto, A; Corrado, F; Crisafulli, A; D'Anna, R; Frisina, N; Inferrera, MA; Marini, H; Marini, R; Romeo, A; Squadrito, F; Squadrito, G | 1 |
3 trial(s) available for deoxypyridinoline and norethindrone acetate
| Article | Year |
|---|---|
The efficacy of two dosages of a continuous combined hormone replacement regimen.
Topics: Aged; Alkaline Phosphatase; Amino Acids; Asian People; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Collagen; Collagen Type I; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Estradiol; Female; Hormone Replacement Therapy; Hot Flashes; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Osteoporosis, Postmenopausal; Peptides; Postmenopause; Prospective Studies; Singapore; Treatment Outcome; Triglycerides; Uterine Hemorrhage | 2002 |
Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study.
Topics: Alkaline Phosphatase; Amino Acids; Bone Density; Combined Modality Therapy; Diet, Fat-Restricted; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Female; Femur; Follicle Stimulating Hormone; Genistein; Humans; Isoenzymes; Lumbar Vertebrae; Middle Aged; Norethindrone; Norethindrone Acetate; Osteoblasts; Osteocalcin; Osteoclasts; Osteoporosis, Postmenopausal; Radiography | 2002 |
Effects of the phytoestrogen genistein on the circulating soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin system in early postmenopausal women.
Topics: Amino Acids; Bone Density; Bone Remodeling; Bone Resorption; Carrier Proteins; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Female; Femur Neck; Genistein; Glycoproteins; Humans; Membrane Glycoproteins; Middle Aged; Norethindrone; Norethindrone Acetate; Osteoprotegerin; Placebos; Postmenopause; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor | 2004 |